Literature DB >> 20572806

ESVS Guidelines: Section A--prevention in patients with carotid stenosis.

Christos D Liapis1, Peter F Bell, Dimitri P Mikhailidis, Juhani Sivenius, Andrew Nicolaides, Jose Fernandes e Fernandes, Giorgio Biasi, Lars Norgren.   

Abstract

Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572806     DOI: 10.2174/157016110792006905

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  3 in total

1.  Statins impair survival of primary human mesenchymal progenitor cells via mevalonate depletion, NF-κB signaling, and Bnip3.

Authors:  Yun Li; Alison L Müller; Melanie A Ngo; Kiranjit Sran; Daniel Bellan; Rakesh C Arora; Lorrie A Kirshenbaum; Darren H Freed
Journal:  J Cardiovasc Transl Res       Date:  2014-12-30       Impact factor: 4.132

2.  The vulnerable plaque: the real villain in acute coronary syndromes.

Authors:  Michael Liang; Aniket Puri; Gerard Devlin
Journal:  Open Cardiovasc Med J       Date:  2011-05-13

Review 3.  Diabetes and carotid artery disease: a narrative review.

Authors:  Niki Katsiki; Dimitri P Mikhailidis
Journal:  Ann Transl Med       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.